Displaying 1 - 20 of 1557
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak In the Matter of US Anesthesia Partners/Guardian Anesthesia
FTC Secures Settlement with Private Equity Firm in Antitrust Roll-Up Scheme Case
Welsh, Carson, Anderson & Stowe, In the Matter of
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Second Pharmacy Benefit Managers Interim Staff Report
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
FTC Announces Refund Claims Process for Consumers Who Bought Deceptively Marketed Golden Sunrise Nutraceutical Products
FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
FTC Staff Sends Warning Letters to Healthcare Plan Marketers and Lead Generators
FTC Approves Modification of Cooperativa De Farmacias Puertorriqueñas Final Commission Order
Statement of Commissioner Melissa Holyoak In the Matter of Cooperativa De Farmacias Puertorriqueña
SuperGoodDeals.com, Inc.
The FTC filed a complaint against SuperGoodDeals.com, Inc. and its owner, Kevin J. Lipsitz, alleging that the defendants falsely promised consumers next-day shipping of facemasks and other personal protective equipment (PPE) to deal with the coronavirus pandemic. In addition, the FTC alleged that some of the other merchandise sold through the SuperGoodDeals website were falsely advertised as “authentic” or “certified.”
Kevin Lipsitz, who defrauded consumers by falsely promising “next day” shipping of facemasks and respirators to consumers at the height of the COVID-19 pandemic, will be banned from selling personal protective equipment (PPE) and be required to turn over more than $145,000 to the FTC.
In December 2024, the FTC sent more than $114,000 to consumers who were deceived by “next day shipping” claims on badly needed personal protective equipment (PPE) by online seller SuperGoodDeals.com.